Treatment of Nonalcoholic Fatty Liver Disease with Total Alkaloids in Rubus aleaefolius Poir through Regulation of Fat Metabolism

Figure 1

Effects of TARAP on hepatic morphology in mHFD rats. Control: “−”, no fat; model: “+++”, fatty hepatocytes occupying >66% of the hepatic parenchyma. PP: “+”, fatty hepatocytes occupying 33% of the hepatic parenchyma; TARAP-L: “++”, fatty hepatocytes occupying 33–66% of the hepatic parenchyma; TARAP-H: “+”, fatty hepatocytes occupying 33% of the hepatic parenchyma; representative images were taken at a magnification ×400.